Industries > Pharma > Epigenetics Diagnostic Report 2019-2029

Epigenetics Diagnostic Report 2019-2029

Analysis by Product (Reagents, Kits, Instruments, Enzymes, Services), by Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-coding RNA, MicroRNA Modification, Chromatin Structures), by Application (Oncology, Non-oncology) and by Region (North America, Europe, Asia Pacific, Latin America, MEA), Company and Country Analysis and Forecasts

PAGES: 166
PRODUCT CODE: PHA0445
SUBMARKET: Biotechnology

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0445 Categories: , Tag:

Market Definition:
• Epigenetics is referred to all molecular pathways modulating the expression of a genotype into a particular phenotype. Epigenetics consistently indicates changes that affect gene activity and expression, but it can also be used to illustrate any heritable phenotypic change.
• It is mainly a study of change in the gene expression without any change in gene sequence. Some of the examples consists of activating changes namely histone acetylation and DNA demethylation, repressive changes like DNA methylation and histone modifications influenced by noncoding RNAs, such as microRNA and long noncoding RNA.

Market Overview and Trends
• There are various epigenetic drugs developed and in clinical trials for aiming at histone deacetylation and DNA methylation enzymes.
• The factor which is predicted to further drive the expansion is the organizations, for example, the National Cancer Institute (NCI), the International Human Epigenome Consortium (IHEC) and the National Institute of Health (NIH) which encourage funding and support to R&D and product development exercises applicable to the field of epigenetics.
• Epigenetics research is paying particular attention to the discovery of treatment options for various types of tumours. The International Cancer Genome Consortium (ICGC) is focusing on acquiring the epigenomic changes, transcriptomic changes and genomic description in different types of tumours.
• With an objective to distinguish all the human genome sequence functional elements the Encyclopaedia of DNA Elements (ENCODE) project was launched by the U.S. National Human Genome Research Institute.

Market Dynamics:

Factors Influencing the Market Growth:
• Increasing frequency of cancer and other chronic diseases and growing geriatric population are some of the key factors predicted to drive the market.
• The factors driving the growth of this market is advancements in screening tools, rising incidence of cancer and huge amounts invested in research and development activities.
• The demand for epigenetic diagnosis and drugs is expected to increase due to the increase in ageing population and rising incidence of oncology and non- oncology disorders.
• Some of the factors contributing to fuelling the growth of the global epigenetics market are the increasing number of retail clinics, companion diagnostics and development of entire genome technology.
• The market is also driven by the increase in research and developmental activities which helps in expanding facilities in various fields such as clinical and pharmaceutical research.

Factors Restraining the Market Growth:
• The growth of epigenetic market is likely to be hampered by the lack of funds from the government and high cost of the procedures and consumers do not wish to invest in such expensive products, especially research groups with limited budgets and funding.

Market Segmentation 2019-2029:
The Epigenetics Diagnostic market is segmented on the product, technology, application and region.

1. Epigenetics Diagnostic, by Product
a) Reagents
b) Kits
– ChIP Sequencing Kit
– Whole Genomic Amplification Kit
– Bisulfite Conversion Kit
– RNA Sequencing Kit
– Others
c) Instruments
d) Enzymes
e) Services

2. Epigenetics Diagnostic, by Technology
a) DNA Methylation
– Reagents
– Kits
– Instruments
– Enzymes
– Services
b) Histone Methylation
– Reagents
– Kits
-Instruments
– Enzymes
– Services
c) Histone Acetylation
– Reagents
– Kits
– Instruments
– Enzymes
– Services
d) Large non-coding RNA
– Reagents
– Kits
– Instruments
-Enzymes
– Services
e) MicroRNA Modification
– Reagents
– Kits
– Instruments
– Enzymes
– Services
f) Chromatin structures
– Reagents
– Kits
– Instruments
– Enzymes
– Services

3. Epigenetics Diagnostic, by Application
a) Oncology
– Solid Tumours
– Liquid Tumours
b) Non-oncology
– Inflammatory Diseases
– Metabolic Diseases
– Infectious Diseases
– Cardiovascular Diseases
– Others

4. Epigenetics Diagnostic, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Celgene Corporation, CellCentric Ltd, Chroma Therapeutics Ltd, Covaris Inc, DIAGENODE, INC., Ribimed Biotechnologies, Epigenomics AG, Epitherapeutics, Epizyme, Karus Therapeutics, Merck Millipore, Novartis International AG, Oncolys Biopharma Inc, OncoMethylome Sciences, Qiagen, Sigma-Aldrich Corporation, Syndax Pharmaceuticals and ZYMO RESEARCH CORPORATION (ZYMO).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Epigenetics Diagnostic Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Epigenetics Diagnostic Report 2019-2029


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories